廣發證券(000776.SZ):成功公開發行80億元公司債券
格隆匯8月15日丨廣發證券(000776.SZ)公佈,廣發證券股份有限公司2021年面向專業投資者公開發行公司債券(第三期)發行規模不超過人民幣80億元(含80億元),發行價格為每張100元,採取網下面向專業投資者詢價配售的方式發行。
本期債券發行時間自2021年8月12日至2021年8月13日,其中品種一發行期限為390天,最終發行規模為46億元,最終票面利率為2.69%;品種二發行期限為2年期,最終發行規模為34億元,最終票面利率為2.90%。
其中,發行人的全資子公司廣發證券資產管理(廣東)有限公司管理的產品參與本期債券品種二的認購,最終獲配金額為6.7億元,佔本期債券發行規模的8.38%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.